MHRA Expands Relationship with Commonwealth Informatics to Transform Drug Safety
Commonwealth Informatics has expanded its partnership with the Medicines and Healthcare products Regulatory Agency (MHRA) to enhance safety monitoring across all medical products in the UK. MHRA will utilize Commonwealth's Vigilance Workbench (CVW) for signal detection, enabling a more responsive safety surveillance system. The integration of CVW with Insife's HALOPV solution will facilitate advanced automation and real-time analytics. This collaboration aims to improve the efficiency and accuracy of safety signal processing, benefitting both patients and public health.
- Expansion of partnership with MHRA enhances safety monitoring across various medical products.
- Implementation of advanced automation and signal management with Commonwealth Vigilance Workbench (CVW) boosts the efficiency of safety surveillance.
- Collaboration with Insife to integrate CVW with HALOPV enhances case processing and real-time analytics capabilities.
- None.
WALTHAM, Mass., Jan. 24, 2022 /PRNewswire/ -- Commonwealth Informatics, an independently-operated subsidiary of Genpact, and leading technology and services company with industry expertise in medical product safety and public health surveillance, today announced that it has expanded its relationship with the Medicines and Healthcare products Regulatory Agency (MHRA), a medical regulatory body for the United Kingdom.
MHRA has selected Commonwealth Informatics' state-of-the-art signal detection and signal management solution, Commonwealth Vigilance Workbench (CVW), to support the MHRA transformation of safety monitoring through a single integrated platform across all medicines, vaccines, blood components and devices.
"The MHRA is looking to transform our vigilance services through new ways of working, underpinned by the technology we use and how we operate our services," said Mick Foy, Head of Pharmacovigilance Strategy at MHRA. "We see our partnership with CVW enabling us to deliver a more responsive safety surveillance system through innovative technology."
"We are delighted to have the opportunity to build on our longstanding research collaboration with the MHRA and deliver future value through greater efficiencies within signal detection," said Bill Blackwell, Commonwealth VP Safety Science Solutions. "The collaborative partnership will enable us, together with the MHRA, to bring new innovative methodologies to safety surveillance on behalf of patients."
Commonwealth's solution will be implemented to perform signal detection and signal management across multiple data sources leveraging advanced automation, such as artificial intelligence, to ensure more accurate multivigilance analysis and processing. CVW is an integrated cloud-based signal management system supporting the detection, tracking and refinement of safety signals using evidence across multiple data sources.
The MHRA is deploying Insife's HALOPV solution for case processing management, advanced automation, and real-time reporting and analytics. Commonwealth Informatics has partnered with Insife, to integrate CVW with HALOPV and to collaboratively deploy the end-to-end multi-vigilance platform in Q2 2022. Insife, headquartered in Denmark, offers specialist consulting services in multivigilance (Medicines and Devices), Regulatory Affairs (RA), and Information Technology (IT) implementation. Insife's services are based on expertise across the life sciences value chain with an understanding of digital transformation and drug safety assurance through process optimisation and automation.
To learn more about CVW and how Commonwealth Informatics is helping to transform the MHRA's safety operations, see www.commoninf.com.
About Commonwealth Informatics
Commonwealth Informatics is a technology and services company with industry expertise in medical product safety and public health surveillance. Pharmaceutical and biotechnology companies, government agencies, and healthcare providers use Commonwealth's products and services to assemble relevant data and answer complex clinical and safety analysis questions quickly and accurately. Commonwealth is an independently-operated subsidiary of Genpact (NYSE: G), a global professional services firm focused on delivering digital transformation. Learn more about the innovative products and services that are helping to improve the speed and accuracy of pharmacovigilance evidence generation at https://www.commoninf.com.
About Medicines and Healthcare products Regulatory Agency
MHRA, based in London, is an executive agency sponsored by the Department of Health and Social Care, that regulates medicines, medical devices and blood components for transfusion in the United Kingdom. Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development.
CONTACT:
Michelle Tully
+1 978-606-7682
mtully@commoninf.com
View original content:https://www.prnewswire.com/news-releases/mhra-expands-relationship-with-commonwealth-informatics-to-transform-drug-safety-301466071.html
SOURCE Commonwealth Informatics, a Genpact company
FAQ
What did Commonwealth Informatics announce on January 24, 2022?
How will the partnership with MHRA impact drug safety in the UK?
What technology will Commonwealth Informatics implement for signal detection?
Which additional system will be integrated with CVW for enhanced safety monitoring?
What benefits does the integration of CVW and HALOPV provide?
